T2	Treatment 64 122	therapy with recombinant tissue-type plasminogen activator
T3	Effect 0 57	Cholesterol crystal embolization-associated renal failure
T4	Drug 101 122	plasminogen activator
T1	Adverse_event 58 63	after
E1	Adverse_event:T1